QA: Northwest Biotherapeutics INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001072379_2017_Northwest_Biotherapeutics_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001072379, Northwest Biotherapeutics INC

  xvar xval
0 AssetsCurrent 7,884,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 315,000
3 remainder_Assets 44,707,000
4 LiabilitiesCurrent 76,405,000
5 LiabilitiesNoncurrent 3,000,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,051,346
9 ResearchAndDevelopmentExpense 38,629,386
10 remainder_Expenses 9,694,770
11 remainder_Revenues 576,622
12 remainder_NetIncome 9,885,538
13 remainder_ComprehensiveNetIncome 11,490,999
  yvar yval
0 Assets 52,906,000
1 Liabilities 79,405,000
2 Expenses 63,375,502
3 Revenues 576,622
4 StockholdersEquity -26,499,000
5 NetIncome -52,913,342
6 ComprehensiveNetIncome -47,167,842
7 BaseVar 108,819,830
8 EconomicCapitalRatiobeforeLimitedLiability -1.59
9 EconomicCapitalRatio 1.15

Edgar->Model Mapping

Feature Distribution

Change over Time